Concord Biotech Overview
- Year Founded
-
1984

- Status
-
Public
- Employees
-
2,401

- Stock Symbol
-
543960

- Investments
-
1
- Share Price
-
$25.50
- (As of Monday Closing)
Concord Biotech General Information
Description
Concord Biotech Ltd is a research and development-driven biopharma company that manufactures Active Pharmaceutical Ingredients (API) through fermentation and semi-synthetic process and finished formulations. It is mainly engaged in the business of manufacturing and trading in pharmaceutical products.
Contact Information
Website
www.concordbiotech.comCorporate Office
- Mondeal Heights, Iscon Cross Road, S.G. Highway
- 16th Floor, B-Wing
- Ahmedabad, Gujarat 380015
- India
Corporate Office
- Mondeal Heights, Iscon Cross Road, S.G. Highway
- 16th Floor, B-Wing
- Ahmedabad, Gujarat 380015
- India
Concord Biotech Stock Performance
As of 10-Feb-2025, Concord Biotech’s stock price is $25.50. Its current market cap is $2.67B with 105M shares.
(As of Monday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$25.50 | $26.74 | $15.97 - $31.79 | $2.67B | 105M | 5.81K | $0.38 |
Concord Biotech Financials Summary
As of 30-Sep-2024, Concord Biotech has a trailing 12-month revenue of $128M.
In Thousands, USD |
TTM 30-Sep-2024 | FY 2024 31-Mar-2024 | FY 2023 31-Mar-2023 | FY 2022 31-Mar-2022 |
---|---|---|---|---|
EV | 2,503,140 | 1,881,796 | ||
Revenue | 127,960 | 120,559 | 103,444 | 95,083 |
EBITDA | 59,212 | 56,250 | 46,840 | 38,689 |
Net Income | 39,331 | 37,217 | 29,899 | 23,478 |
Total Assets | 210,751 | 203,938 | 184,405 | 173,127 |
Total Debt | 409 | 1,168 | 3,842 | 8,241 |
Concord Biotech Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Concord Biotech Patents
Concord Biotech Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20170073374-A1 | A process for isolation pf romidepsin from fermentation broth and preparation of crystals of romidepsin | Active | 04-Mar-2014 | ||
US-10294276-B2 | Process for isolation of romidepsin from fermentation broth and preparation of crystals of romidepsin | Active | 04-Mar-2014 | ||
US-10119158-B2 | Process for the preparation of fidaxomicin | Active | 23-Apr-2013 | ||
US-20160083764-A1 | An improved process for the preparation of fidaxomicin | Active | 23-Apr-2013 | ||
US-20070142424-A1 | Process for producing tacrolimus (fk-506) using vegetable oil as sole source of carbon | Inactive | 29-Jul-2004 | C12P17/188 |
Concord Biotech Signals
Concord Biotech Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Concord Biotech Investments (1)
Concord Biotech’s most recent deal was a Corporate with CleanMax for . The deal was made on 16-Jan-2025.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
CleanMax | 16-Jan-2025 | Corporate | Energy Production |
Concord Biotech ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile

Commercial Services
Industry
Rank
Percentile

Business Support Services
Subindustry
Rank
Percentile

Concord Biotech FAQs
-
When was Concord Biotech founded?
Concord Biotech was founded in 1984.
-
Where is Concord Biotech headquartered?
Concord Biotech is headquartered in Ahmedabad, India.
-
What is the size of Concord Biotech?
Concord Biotech has 2,401 total employees.
-
What industry is Concord Biotech in?
Concord Biotech’s primary industry is Pharmaceuticals.
-
Is Concord Biotech a private or public company?
Concord Biotech is a Public company.
-
What is Concord Biotech’s stock symbol?
The ticker symbol for Concord Biotech is 543960.
-
What is the current stock price of Concord Biotech?
As of 10-Feb-2025 the stock price of Concord Biotech is $25.50.
-
What is the current market cap of Concord Biotech?
The current market capitalization of Concord Biotech is $2.67B.
-
What is Concord Biotech’s current revenue?
The trailing twelve month revenue for Concord Biotech is $128M.
-
What is Concord Biotech’s annual earnings per share (EPS)?
Concord Biotech’s EPS for 12 months was $0.38.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »